Update topic: the uses and effects of the Calmette-Guérin Mycobacterium bovis bacillus (BCG vaccine)
Valdespino Gómez, J.L.
Salud Publica de Mexico 39(2): 93-94
1997
ISSN/ISBN: 0036-3634 PMID: 9254443 Document Number: 469644
Document emailed within 1 workday
Related Documents
Luo, Y.; Chen, X.; Downs, T.M.; DeWolf, W.C.; O'Donnell, M.A. 1999: IFN-alpha 2B enhances Th1 cytokine responses in bladder cancer patients receiving Mycobacterium bovis bacillus Calmette-Guérin immunotherapy Journal of Immunology 162(4): 2399-2405Silver, R.F.; Wallis, R.S.; Ellner, J.J. 1995: Mapping of T cell epitopes of the 30-kDa alpha antigen of Mycobacterium bovis strain bacillus Calmette-Guérin in purified protein derivative (PPD)-positive individuals Journal of Immunology 154(9): 4665-4674
Pedrazzini, T.; Hug, K.; Louis, J.A. 1987: Importance of L3T4+ and Lyt-2+ cells in the immunologic control of infection with Mycobacterium bovis strain bacillus Calmette-Guérin in mice. Assessment by elimination of T cell subsets in vivo Journal of Immunology 139(6): 2032-2037
Méndez-Samperio, P.; Pérez, A.; Trejo, A. 2007: Sphingosine kinase, phosphatidylinositol 3-kinase, Akt, NF-kappaB, and p300 are required for CCL5 production in Mycobacterium bovis Bacillus Calmette-Guérin (BCG)-infected epithelial cells Cellular Immunology 249(2): 94-100
Shapiro, A.; Ratliff, T.L.; Oakley, D.M.; Catalona, W.J. 1983: Reduction of bladder tumor growth in mice treated with intravesical Bacillus Calmette-Guérin and its correlation with Bacillus Calmette-Guérin viability and natural killer cell activity Cancer Research 43(4): 1611-1615
Lee, P.P. 2015: Disseminated Bacillus Calmette-Guérin and Susceptibility to Mycobacterial Infections-Implications on Bacillus Calmette-Guérin Vaccinations Annals of the Academy of Medicine Singapore 44(8): 297-301
Lin, C.J.; Yang, W.S.; Yan, J.J.; Liu, C.C. 1999: Mycobacterium bovis osteomyelitis as a complication of Bacille Calmette-Guérin (BCG) vaccination: rapid diagnosis with use of DNA sequencing analysis: a case report Journal of Bone and Joint Surgery. American Volume 81(9): 1305-1311
Al-Salem, A.H.; Kothari, M.R.; AlHani, H.M.; Oquaish, M.M.; Khogeer, S.S.; Desouky, M.S. 2012: Safety of intradermal Bacillus Calmette-Guerin vaccine for neonates in Eastern Saudi Arabia Saudi Medical Journal 33(2): 172-176
Hakin, A.A. 1976: Action of Bacillus Calmette Guerin vaccine. II. Mechanisms to mount effective immune response against neoplastic proliferation Pharmaceutica Acta Helvetiae 51(4): 98-105
Bruley-Rosset, M.; Florentin, I.; Kiger, N.; Davigny, M.; Mathé, G. 1978: Effects of Bacillus Calmette-Guérin and levamisole on immune responses in young adult and age-immunodepressed mice Cancer Treatment Reports 62(11): 1641-1650
Houchens, D.P.; Goldberg, A.I.; Gaston, M.R.; Kende, M.; Goldin, A. 1973: Studies of the effects of Bacillus Calmette-Guérin on Moloney sarcoma virus-induced tumors in normal and immunosuppressed mice Cancer Research 33(4): 685-690
Zschiesche, W.; Schulz, W.D. 1971: Pseudowasting syndrome and carcinogenesis after 20-methylcholanthrene administration and effects of Mycobacterium Calmette-Guérin (BCG) in newborn and young mice Zeitschrift für Krebsforschung 75(4): 277-287
Cauwels, A.; Fiers, W.; Brouckaert, P. 1996: Murine IL-12 is involved in Calmette-Guérin bacillus-induced sensitization and is by itself sufficient to sensitize mice to the lethal effects of human TNF1 Journal of Immunology 156(12): 4686-4690
Hoover, H.C.; Surdyke, M.; Dangel, R.B.; Peters, L.C.; Hanna, M.G. 1984: Delayed cutaneous hypersensitivity to autologous tumor cells in colorectal cancer patients immunized with an autologous tumor cell: Bacillus Calmette-Guérin vaccine Cancer Research 44(4): 1671-1676
Goupille, P.; Valat, J.P. 1996: Arthritis after bacillus Calmette-Guérin therapy Journal of Rheumatology 23(8): 1481-1482
Vázquez-Lavista, L.G.; Flores-Balcázar, C.H.é; Llorente, L. 2007: The bacillus Calmette-Guérin as immunomodulator in bladder cancer Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 59(2): 146-152
Nesher, G. 1999: Bacillus Calmette-Guérin induced reactive arthritis Journal of Rheumatology 26(7): 1638
Mitsogiannis, I.C.; Psaroudaki, Z.; Perrea, D.; Paniara, O.; Melekos, M.D.; Zervas, A.; Mitropoulos, D. 2006: In vitro biocompatibility between mitomycin-C (MMC) and bacillus Calmette-Guerin (BCG) Anticancer Research 26(6b): 4569-4573
Brosman, S.A. 1992: Bacillus Calmette-Guérin immunotherapy. Techniques and results Urologic Clinics of North America 19(3): 557-564
Cerdá de Palou, E.; de Santy, H.P.R.M. 2003: Lymphadenitis as a complication following vaccination with Bacillus Calmette-Guérin (BCG) Nederlands Tijdschrift Voor Geneeskunde 147(12): 569-572